Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Retatrutide (development code LY3437943) is a 39-amino acid synthetic peptide developed by Eli Lilly as the first triple-receptor agonist targeting GLP-1R, GIPR, and GCGR in a single molecule
Multi-path support can match the complexity of the problem
Taking certain medications like heartburn medicine
It modulates inflammation, helping resolve it at appropriate times rather than allowing it to persist and cause damage
BPC-157 (Body Protection Compound-157), also designated as PL-14736, is a synthetic pentadecapeptide composed of 15 amino acids: (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val)
US$ 25.32
/https://fbi.cults3d.com/uploaders/15875344/illustration-file/3dd28a8f-b526-44c4-9a53-231f6b835d10/2.jpg)
US$ 27.49
US$ 25.43
US$ 21.39
/https://fbi.cults3d.com/uploaders/15875344/illustration-file/6753f671-a403-43b3-bec9-b2d584dea719/2.jpg)
US$ 29.50
US$ 25.05
